Fix failing adat02 template #179
GitHub Actions / Unit Tests Summary
failed
Oct 9, 2024 in 0s
4 fail, 88 skipped, 248 pass in 59s
Annotations
Check warning on line 0 in tables_ADA_adat01
github-actions / Unit Tests Summary
tables_ADA_adat01.qmd_result_v1_development (tables_ADA_adat01) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'development'): ('test-tables-ADA-adat01.R:1:1')
Snapshot of code has changed (variant 'development'):
old[3:24] vs new[3:24]
Output
Baseline Prevalence and Incidence of Treatment Emergent ADA
- ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing> B: Placebo All Drug X
+ A: Drug X C: Combination All Drug X B: Placebo All Patients
- (N=134) (N=132) (N=0) (N=134) (N=266)
+ (N=134) (N=132) (N=266) (N=134) (N=400)
- ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Baseline Prevalence of ADAs
+ Baseline Prevalence of ADAs
- Baseline evaluable patients 134 132 0 0 266
+ Baseline evaluable patients 134 132 266 0 266
- Patient with a positive sample at baseline 63 (47.0%) 64 (48.5%) 0 0 127 (47.7%)
+ Patient with a positive sample at baseline 63 (47.0%) 64 (48.5%) 127 (47.7%) 0 127 (47.7%)
- Patient with no positive samples at baseline 71 68 0 0 139
+ Patient with no positive samples at baseline 71 68 139 0 139
- Incidence of Treatment Emergent ADAs
+ Incidence of Treatment Emergent ADAs
- Post-baseline evaluable patients 134 132 0 0 266
+ Post-baseline evaluable patients 134 132 266 0 266
- Patient positive for Treatment Emergent ADA 0 0 0 0 0
+ Patient positive for Treatment Emergent ADA 0 0 0 0 0
- Treatment-induced ADA 0 0 0 0 0
+ Treatment-induced ADA 0 0 0 0 0
- Treatment-enhanced ADA 0 0 0 0 0
+ Treatment-enhanced ADA 0 0 0 0 0
- Patient negative for Treatment Emergent ADA 0 0 0 0 0
+ Patient negative for Treatment Emergent ADA 0 0 0 0 0
- Treatment unaffected 0 0 0 0 0
+ Treatment unaffected 0 0 0 0 0
- ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies) Baseline evaluable patient = a patient with an ADA assay result from a baseline sample(s)
Post-baseline evaluable patient = a patient with an ADA assay result from at least one post-baseline sample Number of patients positive for Treatment Emergent
* Run `testthat::snapshot_accept('development/tables-ADA-adat01')` to accept the change.
* Run `testthat::snapshot_review('development/tables-ADA-adat01')` to interactively review the change.
Check warning on line 0 in tables_ADA_adat04a
github-actions / Unit Tests Summary
tables_ADA_adat04a.qmd_result_v1_development (tables_ADA_adat04a) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'development'): ('test-tables-ADA-adat04a.R:1:1')
Snapshot of code has changed (variant 'development'):
old[4:27] vs new[4:27]
Baseline Prevalence and Incidence of Treatment Emergent NAbs
Protocol: A: Drug X Antibody
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing> B: Placebo All Drug X
+ A: Drug X C: Combination All Drug X B: Placebo All Patients
- (N=134) (N=132) (N=0) (N=134) (N=266)
+ (N=134) (N=132) (N=266) (N=134) (N=400)
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Baseline Prevalence of NAbs
+ Baseline Prevalence of NAbs
- Baseline evaluable patients for ADA 134 132 0 0 266
+ Baseline evaluable patients for ADA 134 132 266 0 266
- Patients with a positive ADA sample at baseline 63 64 0 0 127
+ Patients with a positive ADA sample at baseline 63 64 127 0 127
- Patients with a positive NAb sample at baseline 0 0 0 0 0
+ Patients with a positive NAb sample at baseline 0 0 0 0 0
- Patient with no positive NAb samples at baseline 0 0 0 0 0
+ Patient with no positive NAb samples at baseline 0 0 0 0 0
- Incidence of Treatment Emergent NAbs
+ Incidence of Treatment Emergent NAbs
- Post-baseline evaluable patients for ADA 134 132 0 0 266
+ Post-baseline evaluable patients for ADA 134 132 266 0 266
- Patients positive for ADA 66 59 0 0 125
+ Patients positive for ADA 66 59 125 0 125
- Patients positive for Treatment Emergent NAb 0 0 0 0 0
+ Patients positive for Treatment Emergent NAb 0 0 0 0 0
- Treatment-induced NAb 0 0 0 0 0
+ Treatment-induced NAb 0 0 0 0 0
- Treatment-enhanced NAb 0 0 0 0 0
+ Treatment-enhanced NAb 0 0 0 0 0
- Patients negative for NAb 0 0 0 0 0
+ Patients negative for NAb 0 0 0 0 0
- Treatment unaffected 0 0 0 0 0
+ Treatment unaffected 0 0 0 0 0
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
NAb = Neutralizing Antibodies ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies) Baseline evaluable patient for ADA = a patient with an ADA assay result from a baseline sample(s)
Baseline evaluable patient for NAb = a patient with a NAb assay result from a baseline sample(s)
* Run `testthat::snapshot_accept('development/tables-ADA-adat04a')` to accept the change.
* Run `testthat::snapshot_review('development/tables-ADA-adat04a')` to interactively review the change.
Check warning on line 0 in tables_ADA_adat04b
github-actions / Unit Tests Summary
tables_ADA_adat04b.qmd_result_v1_development (tables_ADA_adat04b) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'development'): ('test-tables-ADA-adat04b.R:1:1')
Snapshot of code has changed (variant 'development'):
old[4:24] vs new[4:24]
Baseline Prevalence and Incidence of Neutralizing Antibodies (NAbs)
Protocol: A: Drug X Antibody
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing> B: Placebo All Drug X
+ A: Drug X C: Combination All Drug X B: Placebo All Patients
- (N=134) (N=132) (N=0) (N=134) (N=266)
+ (N=134) (N=132) (N=266) (N=134) (N=400)
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Baseline Prevalence of NAbs
+ Baseline Prevalence of NAbs
- Baseline evaluable patients for ADA 134 132 0 0 266
+ Baseline evaluable patients for ADA 134 132 266 0 266
- Patients with a positive ADA sample at baseline 63 64 0 0 127
+ Patients with a positive ADA sample at baseline 63 64 127 0 127
- Patients with a positive NAb sample at baseline 0 0 0 0 0
+ Patients with a positive NAb sample at baseline 0 0 0 0 0
- Patients with no positive NAb sample at baseline 0 0 0 0 0
+ Patients with no positive NAb sample at baseline 0 0 0 0 0
- Incidence of NAbs
+ Incidence of NAbs
- Post-baseline evaluable patients for ADA 134 132 0 0 266
+ Post-baseline evaluable patients for ADA 134 132 266 0 266
- Patients positive for ADA 66 59 0 0 125
+ Patients positive for ADA 66 59 125 0 125
- Patients positive for NAb 0 0 0 0 0
+ Patients positive for NAb 0 0 0 0 0
- Patients negative for NAb 134 132 0 0 266
+ Patients negative for NAb 134 132 266 0 266
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
NAb = Neutralizing Antibodies ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies) Baseline evaluable patient for ADA = a patient with an ADA assay result from a baseline sample(s) Baseline evaluable patient for NAb = a patient with a NAb assay result from a baseline sample(s) Post-baseline evaluable patient for ADA = a patient with an ADA assay result from at least one post-baseline sample Post-baseline evaluable patient for NAb = a patient with a NAb assay result from at least one post-baseline sample Number of patients positive for ADA = the number of post-baseline evaluable patients for ADA determined to have Treatment Emergent ADA during the study period.
Number of patients positive for NAb = the number (and percentage) of post-baseline evaluable patients for ADA determined to have at least one positive post-baseline NAb result during the study period. Number of patients negative for NAb = number of post-baseline evaluable patients with all negative post-baseline NAb results.
* Run `testthat::snapshot_accept('development/tables-ADA-adat04b')` to accept the change.
* Run `testthat::snapshot_review('development/tables-ADA-adat04b')` to interactively review the change.
Check warning on line 0 in tables_efficacy_mmrmt01
github-actions / Unit Tests Summary
tables_efficacy_mmrmt01.qmd_result_v1_development (tables_efficacy_mmrmt01) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'development'): ('test-tables-efficacy-mmrmt01.R:1:1')
Snapshot of code has changed (variant 'development'):
old[11:17] vs new[11:17]
Difference in Adjusted Means (SE) 0.759 (0.973) -0.325 (0.976)
95% CI (-1.155, 2.672) (-2.243, 1.593)
Relative Increase (%) 21.8% -9.3%
- p-value (MMRM) 0.4362 0.7394
+ p-value (MMRM) 0.4362 0.7393
WEEK 2 DAY 15
n 134 134 132
Adjusted Mean (SE) 9.135 (0.768) 9.018 (0.767) 8.509 (0.773)
old[19:25] vs new[19:25]
Difference in Adjusted Means (SE) -0.117 (1.087) -0.626 (1.090)
95% CI (-2.253, 2.020) (-2.768, 1.517)
Relative Increase (%) -1.3% -6.8%
- p-value (MMRM) 0.9146 0.5662
+ p-value (MMRM) 0.9147 0.5662
WEEK 3 DAY 22
n 134 134 132
Adjusted Mean (SE) 13.547 (0.871) 16.014 (0.871) 15.789 (0.877)
* Run `testthat::snapshot_accept('development/tables-efficacy-mmrmt01')` to accept the change.
* Run `testthat::snapshot_review('development/tables-efficacy-mmrmt01')` to interactively review the change.
Loading